Brooks Automation Inc (BRKS, Financial) files its latest 10-K with SEC for the fiscal year ended on September 30, 2018. Brooks Automation Inc is a provider of automation and cryogenic solutions for multiple applications and markets. The company serves the semiconductor capital equipment market and sample management market for life sciences. Brooks Automation Inc has a market cap of $2.16 billion; its shares were traded at around $30.50 with a P/E ratio of 18.48 and P/S ratio of 2.79. The dividend yield of Brooks Automation Inc stocks is 1.32%. Brooks Automation Inc had annual average EBITDA growth of 46.20% over the past five years.
For the last quarter Brooks Automation Inc reported a revenue of $159.6 million, compared with the revenue of $181.9 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $631.6 million, a decrease of 8.9% from the previous year. For the last five years Brooks Automation Inc had an average revenue growth rate of 9.3% a year.
The reported diluted earnings per share was $1.64 for the year. The Brooks Automation Inc had an operating margin of 5.09%, compared with the operating margin of 9.72% a year before. The 10-year historical median operating margin of Brooks Automation Inc is 4.50%. The profitability rank of the company is 7 (out of 10).
At the end of the fiscal year, Brooks Automation Inc has the cash and cash equivalents of $197.7 million, compared with $101.6 million in the previous year. The long term debt was $194.1 million. The interest coverage to the debt is 3.4. Brooks Automation Inc has a financial strength rank of 7 (out of 10).
At the current stock price of $30.50, Brooks Automation Inc is traded at 93.9% premium to its historical median P/S valuation band of $15.73. The P/S ratio of the stock is 2.79, while the historical median P/S ratio is 1.43. The stock gained 10.89% during the past 12 months.
CEO Recent Trades:
- CEO Stephen S Schwartz sold 8,127 shares of BRKS stock on 11/16/2018 at the average price of $28.59. The price of the stock has increased by 6.68% since.
- CEO Stephen S Schwartz sold 94,826 shares of BRKS stock on 11/12/2018 at the average price of $30.93. The price of the stock has decreased by 1.39% since.
- CEO Stephen S Schwartz sold 3,976 shares of BRKS stock on 11/05/2018 at the average price of $31.76. The price of the stock has decreased by 3.97% since.
CFO Recent Trades:
- EVP & CFO Lindon G Robertson sold 3,675 shares of BRKS stock on 11/16/2018 at the average price of $28.59. The price of the stock has increased by 6.68% since.
- EVP & CFO Lindon G Robertson sold 40,040 shares of BRKS stock on 11/12/2018 at the average price of $30.93. The price of the stock has decreased by 1.39% since.
- EVP & CFO Lindon G Robertson sold 1,796 shares of BRKS stock on 11/05/2018 at the average price of $31.76. The price of the stock has decreased by 3.97% since.
Directors and Officers Recent Trades:
- Chief Strategy & New Business David C Gray sold 2,636 shares of BRKS stock on 11/19/2018 at the average price of $28.31. The price of the stock has increased by 7.74% since.
- President-Brooks Life Sciences Maurice H. Tenney sold 3,461 shares of BRKS stock on 11/16/2018 at the average price of $28.59. The price of the stock has increased by 6.68% since.
- VP, General Counsel, Secretary Jason Joseph sold 1,946 shares of BRKS stock on 11/16/2018 at the average price of $28.59. The price of the stock has increased by 6.68% since.
- SVP, Human Resources William T. Montone sold 1,337 shares of BRKS stock on 11/16/2018 at the average price of $28.59. The price of the stock has increased by 6.68% since.
- Principal Accounting Officer David Pietrantoni sold 1,048 shares of BRKS stock on 11/16/2018 at the average price of $28.59. The price of the stock has increased by 6.68% since.
For the complete 20-year historical financial data of BRKS, click here.
